More studies should be carried out to investigate the effect of [TIMP-2] • [IGFBP7] in predicting AKI and the progress of the disease and determine its clinical usage in the phenotyping of clinical AKI in patients with COVID-19 (Table 1). This evidence concerns the gene TIMP2 and acute kidney injury.